Ipsen (France)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (France), France, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
41%
Total
Publications
1.9K
Total Open
Publications
793
Total
Citations
40K
Open Access
Percentage
41%
Total
Publications
1.9K
Total Open
Publications
793
Total
Citations
40K
Breakdown
Publisher Open
16%
Both
22%
Other Platform Open
3%
Closed
59%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
265
Hybrid 41%
292
No Guarantees 22%
156
Other Platform Open
Domain 75%
365
Institution 37%
181
Other Internet 16%
77
Public 3%
17
Preprint 1%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 367 |
DOI | Other Internet | 75 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 41 |
Europe PMC | Domain | 33 |
DANS - Data Archiving and Networked Services | Institution | 19 |
Digital Access to Libraries | Institution | 15 |
Figshare | Public | 14 |
King's College London - Research Portal | Institution | 13 |
Konstfack University of Arts, Crafts, and Design - Publications | Institution | 12 |
Academy of Humanities and Economics in Lodz - Homo Politicus | Institution | 10 |